GoKawiilExin Therapeutics has AI agent select and deliver gene therapy during mouse brain surgery
Biotech startup Exin Therapeutics says an AI agent built on Anthropic's Sonnet model independently selected a gene therapy vector, dosage and brain target from 19 candidate treatments to address seizures in a mouse model of epilepsy, then operated a motorized stereotaxic rig to inject the therapy while monitoring for bleeding via camera. CEO Gabriel Ocana-Santero documented the procedure on X, noting a licensed veterinarian supervised with a physical kill switch at every irreversible step, and the mouse reportedly recovered and was seen moving normally afterward.
GoKawiil's interpretation of the reporting above, not reported fact.
Ocana-Santero frames this as a step beyond existing surgical robots, which execute procedures humans have already decided on, since here the AI reportedly chose both the treatment and the target itself. If accurate, this could signal growing use of AI agents in experimental biomedical decision-making, though the claims rest on a single unpublished demonstration shared on social media rather than peer-reviewed data, leaving questions about reproducibility, safety oversight, and regulatory scrutiny unresolved.
- An AI agent reportedly chose a gene therapy vector, dosage and brain region from 19 candidates for a mouse epilepsy model.
- The agent controlled a motorized stereotaxic rig to deliver the injection while monitoring the site via camera, with a vet able to intervene.
- The claims were shared by the startup's CEO on X rather than through a peer-reviewed publication.
Source: tomshardware.com — Jowi Morales, 2026-10-31
Published there as: “AI agent used to perform controversial brain surgery on a mouse, Anthropic Sonnet controlled motorized surgery rig”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.